CD4 and neoplasm: showed that tumor infiltrating B cells can present endogenous tumor antigen to CD4+ TILs, changing the CD4+ TILs phenotype in vitro, and that the activated tumor infiltrating B cells were related to the activated IFN-γ CD4+ T cell response (42).